• Consultation growth of 7.5% year-on-year (excluding secondary care)
• New clinical pathways launched in Mental Health, Musculoskeletal, and Skin Cancer care
• Second consecutive quarter of positive cash generation, with £0.6m net operating and investing cash inflow

Doctor Care Anywhere Group Plc (ASX:DOC) reported its quarterly activities and cash flow for Q3 2025. Key highlights include:- Consultation growth of 7.5% year-on-year (excluding secondary care), driven by new service offerings and platform enhancements- Launch of new clinical pathways in Mental Health, Musculoskeletal, and Skin Cancer care, differentiating the company's offering and demonstrating its ability to deliver accessible, patient-centred care at lower cost- Second consecutive quarter of positive cash generation, with £0.6m (A$1.2m) net operating and investing cash inflow, compared to a £0.9m (A$1.8m) outflow in Q3 2024- Strong cash position of £5.4m (A$11.0m) at quarter-end, providing a solid foundation for investing in business growth- Reiteration of medium-term targets, including revenue doubling over 3-5 years and a 15% EBITDA marginThe company also provided updates on its product expansion initiatives and ongoing operational transformation efforts, which are delivering tangible benefits for patients and clients while freeing up resources for growth.

Management reiterates medium-term targets, including revenue doubling over 3-5 years and a 15% EBITDA margin.